Should You Buy AST SpaceMobile Stock While It's Trading Below $60?

AST SpaceMobile reported revenue of $31.5 million in its latest quarter, up from less than $1.2 million a year earlier, and expects $150 million–$200 million in revenue this year; its backlog is $1.3 billion. The company’s quarterly net loss widened to $230.9 million from $99.4 million, while its shares are down nearly 60% from a high near $134 amid investor concerns about competition from SpaceX. The article presents the lower share price as a possible opportunity for long-term investors but emphasizes the company’s unprofitability and volatility.

Analysis

The investment question is conversion, not addressable-market size. ASTS’s reported backlog and operator relationships have value only if satellite deployment, service quality, and commercial terms turn them into recurring revenue. Until then, rapid top-line growth from a small base can coexist with rising cash needs; the key equity risk is that deployment spending and operating losses outrun funding capacity, forcing dilution before scale economics are demonstrated.

Over the next 1–3 months, focus on cash burn and financing disclosures, deployment milestones, and whether guidance is met—not subscriber coverage claims alone. Over 6–18 months, SpaceX’s potential advantage is not simply investor attention: launch cadence, constellation scale, and leverage in operator negotiations could pressure ASTS’s pricing or delay adoption. Conversely, direct-to-cell may expand the market enough for multiple networks, but that does not guarantee attractive returns for every provider. No evidence here establishes comparable service, pricing, or unit economics.

Contrarian point: the selloff may price competition more clearly than execution and funding risk. The backlog is not equivalent to contracted, near-term recognized revenue, and the cited growth rate is not evidence of improving margins. Without cash runway, capex, backlog conversion terms, and deployment reliability, the valuation case is difficult to underwrite. Treat ASTS as a high-volatility execution option rather than a proven compounder; avoid assuming SPCX’s scale automatically makes ASTS uneconomic.

Key Decisions for Investors

• Do not chase ASTS solely on the drawdown or headline growth. Consider a staged, small position only after confirming cash runway and a credible path from deployment milestones to revenue; size for potential dilution and sharp volatility.
• Watch the next results for cash use, capital-raising plans, deployment progress, and evidence that backlog converts into delivered service and recognized revenue. A rising cash burn without schedule progress, or a guidance cut, would invalidate the constructive case.
• For a relative-value expression, consider ASTS underweight versus SPCX only if the instruments are accessible and liquid; the thesis is potential scale-driven pressure on ASTS’s commercial economics, not a claim that the two have equivalent businesses or current unit economics.
• Reassess if ASTS demonstrates reliable deployments and improving cash efficiency, or if operator commitments translate into measurable service uptake; those would weaken the competition-led underweight thesis.